Molecular Docking and ADMET Prediction of Modified and Derivative Forms of 2-Deoxy-D-glucose against COVID-19 Main Protease Complex: In silico Approach
Preprint
- 17 January 2023
- preprint
- Published by MDPI AG in Preprints.org
Abstract
The outbreak of Coronavirus, as well as its emerging potential consequences, has become a global challenge worldwide, demanding effective and controlled therapeutic strategies. Potential drug candidates could achieve that with minimal toxicity. The current investigation selected 2-Deoxy-D-glucose prescribed by Defense Research and Development Organization (DRDO), India. The derivative and modified form was tested through in silico analysis against COVID-19 main protease complex with N3 inhibitor. The derived form of 2-Deoxy-D-glucose was generated by replacing the hydroxy group with a hydrogen atom, and Cypate 2-Deoxy-D-glucose was chosen as a derivative against the COVID-19 main protease complex. A molecular docking approach was adopted to identify the stable and competent form among the modified and derivative forms of 2-Deoxy-D-glucose based on binding energy. By further promoting the stabilized complex, these compounds' toxicity was also scrutinized through ADMET analysis to predict the potential candidate. The current investigation suggested that the modified version of 2-Deoxy-D-glucose was more stable with minimal toxicity against COVID-19 main protease.Keywords
All Related Versions
This publication has 40 references indexed in Scilit:
- Identification of phytocompounds from Houttuynia cordata Thunb. as potential inhibitors for SARS-CoV-2 replication proteins through GC–MS/LC–MS characterization, molecular docking and molecular dynamics simulationMolecular Diversity, 2021
- The Complexity of Co-Infections in the Era of COVID-19SN Comprehensive Clinical Medicine, 2021
- Plant‐derived chemicals as potential inhibitors of SARS‐CoV‐2 main protease (6LU7), a virtual screening studyPhytotherapy Research, 2021
- Cellular toxicity of the metabolic inhibitor 2-deoxyglucose and associated resistance mechanismsBiochemical Pharmacology, 2020
- The evolution of strategies to minimise the risk of human drug-induced liver injury (DILI) in drug discovery and developmentArchives of Toxicology, 2020
- Review of Emerging Pharmacotherapy for the Treatment of Coronavirus Disease 2019Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2020
- Drug-induced liver injury: Interactions between drug properties and host factorsJournal of Hepatology, 2015
- Comparison of near‐infrared fluorescent deoxyglucose probes with different dyes for tumor diagnosis in vivoContrast Media & Molecular Imaging, 2012
- Systemic low‐molecular weight drug delivery to pre‐selected neuronal regionsEMBO Molecular Medicine, 2011
- Verification of protein structures: Patterns of nonbonded atomic interactionsProtein Science, 1993